 |
|
Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease
Yue Wang, Sherlot Juan Song, Yichong Jiang, Jimmy Che-To Lai, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
Clin Mol Hepatol. 2025;31(Suppl):S51-S75. Published online 2024 Jun 27 DOI: https://doi.org/10.3350/cmh.2024.0246
|
|
Citations to this article as recorded by
 Prediction of major liver-related events in the population using prognostic models
Fredrik Åberg, Ville Männistö
Gastroenterology Report.2025;[Epub] CrossRef Clinical and Economic Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Spanish Mediterranean Region: A Population-Based Study
Javier Díaz Carnicero, Inma Saurí-Ferrer, Josep Redon, Jorge Navarro, Gonzalo Fernández, Carlos Hurtado, Karine Ferreira, Carolina Alvarez-Ortega, Antón Gómez, Carlos J. Martos-Rodríguez, David Martí-Aguado, Desamparados Escudero, Marta Cedenilla
Journal of Clinical Medicine.2025; 14(7): 2441. CrossRef Preface
Seung Up Kim
Clinical and Molecular Hepatology.2024; 30(Suppl): S3. CrossRef
|